Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Net Cash Flow: 2019-2024

Historic Net Cash Flow for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to -$20.0 million.

  • Relay Therapeutics' Net Cash Flow fell 226.82% to -$22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.3 million, marking a year-over-year decrease of 14001.81%. This contributed to the annual value of -$20.0 million for FY2024, which is 152.71% down from last year.
  • Latest data reveals that Relay Therapeutics reported Net Cash Flow of -$20.0 million as of FY2024, which was down 152.71% from -$7.9 million recorded in FY2023.
  • Relay Therapeutics' Net Cash Flow's 5-year high stood at $405.7 million during FY2020, with a 5-year trough of -$165.8 million in FY2021.
  • Over the past 3 years, Relay Therapeutics' median Net Cash Flow value was -$20.0 million (recorded in 2024), while the average stood at -$52.1 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first spiked by 206.89% in 2020, then slumped by 152.71% in 2024.
  • Relay Therapeutics' Net Cash Flow (Yearly) stood at $405.7 million in 2020, then tumbled by 140.88% to -$165.8 million in 2021, then grew by 22.62% to -$128.3 million in 2022, then surged by 93.82% to -$7.9 million in 2023, then tumbled by 152.71% to -$20.0 million in 2024.